MAAT INDEX
Rankings
74.1 /100

3M Company (MMM)

INDUSTRIALS · 227 verified grades · SandbagsBIASMedian signed deviation across numeric graded claims. Sandbags: outcomes land favorable to guidance. Overpromises: the opposite. Needs at least 6 numeric claims.

Verify independently: SEC filings ↗

What management is on the hook for (316)

hedged · expects · high conviction
2026 Q3 (38)38 open
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We see ourselves marching ahead and with an ability to hit the high-40s over time, you know, but the roadmap is relatively clear.
WHAT TO LOOK FOR
Company's operating margin (%), as reported
Operating margin reaches at least 48% SourceWHERE TO FIND ITQuarterly/annual income statement or investor presentation disclosing operating margin

KNOWABLE AFTER2028-12-31
gross_margin · made Jul 21, 2026 · due Dec 31, 2028
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Along with growth, we are seeing good operating margin expansion and are tracking ahead of the approximately 25% margin rate by 2027.
WHAT TO LOOK FOR
Company-reported operating margin rate (full fiscal year)
Operating margin rate >= 25% for fiscal year 2027 SourceWHERE TO FIND ITCompany income statement / annual report (10-K) and management commentary on 2027 earnings calls

KNOWABLE AFTER2028-02-15
operating_margin · made Jul 21, 2026 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Our growth trajectory continues to accelerate from commercial excellence and innovation, and is on track to exceed the $1 billion above macro commitment.
WHAT TO LOOK FOR
Cumulative incremental sales growth attributable to 'above macro' commercial excellence and innovation, versus the Investor Day baseline, measured through the commitment period
Cumulative above-macro sales contribution > $1 billion by the stated deadline SourceWHERE TO FIND ITCompany Investor Day / earnings call management commentary and investor presentation slides tracking progress against the $1 billion above-macro commitment

KNOWABLE AFTER2027-12-31
made Jul 21, 2026 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.otherCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Given our strong first half performance, we are raising our guidance for the year for sales, EPS, and free cash flow.
WHAT TO LOOK FOR
Full-year sales growth, EPS, and free cash flow, as guided
Full-year reported figures meet or exceed the raised guidance ranges given for sales growth, EPS, and free cash flow SourceWHERE TO FIND ITCompany press release / guidance table (Q4 earnings release and full-year 10-K)

KNOWABLE AFTER2027-02-15
revenue · made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
Over time that go up to 30%, maybe a little bit better than that. It will be a little bit higher in the industrial side. So we do expect TEBG and SIBG to get to 40% or beyond 40% class fours and fives, but we are still running as a company around 25% today.
WHAT TO LOOK FOR
Company-wide mix of Class 4/5 new product launches (NPI) as a percentage of total launches (vs. Class 3)
Company-wide Class 4/5 launch share >= 30%, with TEBG and SIBG segments >= 40% SourceWHERE TO FIND ITmanagement commentary on future earnings calls / investor presentations discussing NPI mix

KNOWABLE AFTER2028-12-31
made Jul 21, 2026 · due Dec 31, 2028
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
You know, we expect to outperform in the back half of the year, but the market is getting weaker because of memory.
WHAT TO LOOK FOR
Company's consumer electronics segment sales growth (or decline) rate versus overall market decline rate, back half of fiscal year
Company's consumer electronics sales decline rate is less severe than the market's reported high-teens percentage decline for the back half SourceWHERE TO FIND ITManagement commentary on subsequent earnings calls / company segment reporting

KNOWABLE AFTER2026-12-31
made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
I would say it is normal seasonality with the, EPS growing by 30 seconds, 30¢ in the back half equal between Q3 and Q4.
WHAT TO LOOK FOR
EPS growth in the back half of fiscal 2026 (Q3+Q4 combined), split roughly equally between Q3 and Q4
Combined Q3+Q4 EPS increase versus prior-year Q3+Q4 EPS approximately $0.30, with roughly even split (~$0.15 each) between Q3 and Q4 SourceWHERE TO FIND ITQuarterly earnings release / income statement (Q3 and Q4 FY2026 EPS figures)

KNOWABLE AFTER2026-12-31
eps · made Jul 21, 2026 · for H2 FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
You should see the normal seasonality. Through the course of the year as well. You know, our guide says we are gonna be over 3.5% for the year.
WHAT TO LOOK FOR
Full-year organic revenue growth (or comparable topline growth metric as guided), fiscal 2026
Full-year growth rate > 3.5% SourceWHERE TO FIND ITCompany income statement / earnings release and management commentary (Q4 2026 / full-year results)

KNOWABLE AFTER2027-01-31
revenue · made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
You know, but even with the tough compares, we think know, second half will be pretty strong growth well.
WHAT TO LOOK FOR
Revenue growth rate (year-over-year), second half of fiscal year
H2 year-over-year revenue growth > H1 year-over-year revenue growth rate SourceWHERE TO FIND ITQuarterly income statement / earnings release (Q3 and Q4 reports)

KNOWABLE AFTER2027-01-31
made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capexCONVICTIONStated expectation · “we expect”, “should”, “we see”
And on investments, we said it is going to be $225 million, and the investments are spread over growth, productivity, and foundation of about $225 million, $75 million in the first half, $150 million in the second half.
WHAT TO LOOK FOR
Total company investment spend for growth, productivity, and foundation initiatives, full fiscal year, with first-half/second-half split
Full-year investment spend approximately $225 million (within +/-10%), with first-half spend approximately $75 million and second-half spend approximately $150 million SourceWHERE TO FIND ITCompany management commentary / investor presentation on full-year results (Q4 earnings call or 10-K MD&A)

KNOWABLE AFTER2026-12-31
made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Just on the static cost, it is still $150 million for the year, more in the second half versus the first half.
WHAT TO LOOK FOR
Static (stranded) costs for the full fiscal year
Full-year static costs approximately $150 million (within +/-10%), with second-half costs exceeding first-half costs SourceWHERE TO FIND ITCompany management commentary / investor presentation disclosing stranded cost figures (earnings call or 10-K MD&A)

KNOWABLE AFTER2026-12-31
made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.competitionCONVICTIONStated expectation · “we expect”, “should”, “we see”
But over time, you know, given our technology and the momentum we think we are building here and our ability to scale, we think our share in that segment will grow materially.
WHAT TO LOOK FOR
Company's revenue/share in the Expanded Beam Optics connector segment, as disclosed by management (currently cited as $40-50 million of a ~$1 billion market)
Disclosed segment revenue or share materially above the $40-50 million baseline (e.g., >$75 million or company-stated share percentage roughly doubling from current ~4-5%) SourceWHERE TO FIND ITManagement commentary on quarterly earnings calls (segment/market share disclosures)

KNOWABLE AFTER2028-12-31
made Jul 21, 2026 · due Dec 31, 2028
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
You know, we do expect good momentum going into the back half of the year.
WHAT TO LOOK FOR
Organic revenue growth rate, back half of fiscal year (Q3+Q4)
Back half organic growth rate higher than back half of prior year / consistent with 'good momentum' framing (growth > 0%, and sequentially improving vs first half comparisons cited) SourceWHERE TO FIND ITCompany quarterly earnings release / income statement (Q3 and Q4 reports)

KNOWABLE AFTER2027-02-15
made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
The Auto Aftermarket business, we think, was Going To Be Soft, Repair Claims Is Still Expected To Be Down In The Back Half Of The Year
WHAT TO LOOK FOR
Auto Aftermarket segment revenue growth (organic/repair claims-driven) in the back half of fiscal year
H2 Auto Aftermarket segment revenue growth < 0% year-over-year SourceWHERE TO FIND ITmanagement commentary / segment disclosure on Q3 and Q4 earnings calls

KNOWABLE AFTER2027-02-15
made Jul 21, 2026 · for H2 FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Auto is stabilizing In General For Us, But it is Still Expected To Be Down On The Build Rate Year Over Year In The Back Half.
WHAT TO LOOK FOR
Auto end-market build rate / auto-related sales growth year-over-year, back half of fiscal year
Auto build rate or auto-related revenue growth < 0% year-over-year for back half (H2) SourceWHERE TO FIND ITmanagement commentary on Q3/Q4 earnings calls and segment revenue disclosure (10-K/10-Q)

KNOWABLE AFTER2027-02-15
made Jul 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
we see some improvements in the back half on easier comps and you know, we do see some tailwind on pricing, you know, for the year will be about 1.5 which implies about 2 points in the back half.
WHAT TO LOOK FOR
Full-year pricing contribution to organic growth (percentage points), and implied second-half pricing contribution
Full-year pricing ~1.5 points (within 1.3-1.7) AND second-half pricing ~2.0 points (within 1.8-2.2) SourceWHERE TO FIND ITmanagement commentary / organic growth bridge disclosed in quarterly earnings release or investor presentation

KNOWABLE AFTER2027-01-31
made Jul 21, 2026 · for H2 FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
But we feel it is gonna normalize here and help us in the back half of consumer to be flat to up slightly, is what our expectation would be in the back half of the year.
WHAT TO LOOK FOR
Consumer Business Group (CBG) revenue growth, second half of fiscal year vs prior year
H2 CBG revenue growth >= 0% (flat to slightly positive) SourceWHERE TO FIND ITCompany segment reporting (10-Q/10-K or earnings call commentary on CBG segment results)

KNOWABLE AFTER2026-12-31
made Jul 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
So as we get into Q3, we feel good visibility, for this Q3 and the 2nd half of the year.
WHAT TO LOOK FOR
Revenue growth (organic/reported) for Q3 and second half of fiscal year
Q3 and H2 revenue growth consistent with continued positive momentum, i.e. growth rate >= Q2's reported 5.4% SourceWHERE TO FIND ITQuarterly income statement / earnings release (Q3 and Q4 reports)

KNOWABLE AFTER2026-12-31
made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
You will see more impact in the back half of the year as those products that we started to work on a few years ago start to launch this year and become meaningful in the back half. They will be even more meaningful into 2027.
WHAT TO LOOK FOR
Revenue growth contribution/acceleration from new product launches, as described in company commentary (e.g., organic sales growth rate and management commentary on new product impact)
Second-half 2026 organic revenue growth rate higher than first-half 2026 organic revenue growth rate, with management attributing acceleration to new product launches SourceWHERE TO FIND ITQuarterly earnings releases and management commentary on Q3/Q4 2026 earnings calls (10-Q/10-K and call transcripts)

KNOWABLE AFTER2027-02-15
made Jul 21, 2026 · due Dec 31, 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capacityCONVICTIONStated expectation · “we expect”, “should”, “we see”
And earlier this year, we announced that we would double our capacity on Expanded Beam Optics this year and another doubling over the next year to 18 months.
WHAT TO LOOK FOR
Expanded Beam Optics production capacity (units or capacity metric as disclosed by company)
Reported capacity >= 2x the capacity level at start of this year (first doubling), and >= 4x that starting level within 12-18 months (second doubling) SourceWHERE TO FIND ITmanagement commentary on earnings calls / investor presentations discussing Expanded Beam Optics capacity

KNOWABLE AFTER2028-01-21
made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
The revenue this year, it was in the $40, $50 million range. You know, we do think it will scale over time. Could be you know, 4x or 5x that or even more over the next several years, depending upon our progress here as well as the adoption of optical technologies and data centers.
WHAT TO LOOK FOR
Annual revenue from Expanded Beam Optics technology
>= 4x the $40-50 million base ($160-200 million annualized), within the next several years SourceWHERE TO FIND ITManagement commentary on earnings calls / segment disclosure

KNOWABLE AFTER2028-12-31
made Jul 21, 2026 · due Dec 31, 2028
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we look to the back half of the year, we do see the innovation engine contributing even more in the back half and in fact, greater into 2027.
WHAT TO LOOK FOR
Sales growth above market/macro growth rate (company-reported organic growth vs. end-market growth), full year
Full-year 2026 growth above macro >= $450 million, as guided SourceWHERE TO FIND ITCompany quarterly earnings call commentary and investor presentations (management-disclosed growth-above-macro metric)

KNOWABLE AFTER2027-01-31
made Jul 21, 2026 · due Dec 31, 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
So we feel pretty good this year. We think we will be about $450 million above macro in the full year.
WHAT TO LOOK FOR
Company organic sales growth performance above market/macro growth rate, full year, expressed in dollar terms
Full-year outperformance vs. macro >= $450 million (as defined/disclosed by company) SourceWHERE TO FIND ITManagement commentary on Q4/full-year earnings call or investor presentation discussing performance versus market growth

KNOWABLE AFTER2027-02-15
made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
And on cash, we expect to continue the strong trajectory exceeding our cumulative cash commitment and $10 billion return to shareholders.
WHAT TO LOOK FOR
Cumulative shareholder returns (dividends + buybacks) since Investor Day baseline, compared to the cumulative cash commitment target
Cumulative cash returned to shareholders >= $10 billion cumulative commitment referenced (exceeding the stated commitment) SourceWHERE TO FIND ITCompany-disclosed cash flow statement and shareholder return commentary (10-K/10-Q and investor presentations through fiscal 2027)

KNOWABLE AFTER2027-12-31
made Jul 21, 2026 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
For earnings, we are trending to a double digit CAGR reflecting strong operational improvements coupled with below the line efficiency.
WHAT TO LOOK FOR
EPS compound annual growth rate (CAGR) over the multi-year Investor Day period
Reported EPS CAGR >= 10% over the stated multi-year period ending fiscal 2027 SourceWHERE TO FIND ITCompany-disclosed EPS figures (10-K / annual earnings release / Investor Day update)

KNOWABLE AFTER2027-12-31
eps · made Jul 21, 2026 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Sequentially, we expect operating profit to follow typical seasonality with similar phasing between the halves while earnings will see an impact from tax timing.
WHAT TO LOOK FOR
Operating profit phasing between first-half and second-half fiscal year, and EPS growth versus prior year
Second-half operating profit follows typical seasonal split similar to first-half/second-half pattern in prior years, and full-year EPS growth of approximately $0.30 at midpoint versus prior year SourceWHERE TO FIND ITQuarterly income statement and management commentary (10-Q/10-K and earnings call)

KNOWABLE AFTER2026-12-31
eps · made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
The updated guidance implies second half organic sales growth of high-3s or better over 2x macro and margin expansion of about 100 basis points from the prior year resulting in EPS growth of approximately $0.30 at the midpoint.
WHAT TO LOOK FOR
Second-half organic sales growth, operating margin change vs prior year, and full-year EPS growth (as reported by 3M)
H2 organic sales growth >= 3.7% AND operating margin expansion >= 90 basis points vs prior year AND full-year EPS growth approximately $0.30 (within $0.05) at midpoint SourceWHERE TO FIND IT3M quarterly earnings releases and income statement (Q3 and Q4 2026 reports)

KNOWABLE AFTER2027-02-01
revenue · made Jul 21, 2026 · for H2 FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
Given the higher earnings growth, and progress in working capital, we have increased our free cash flow guidance by $100 million to a $4.7 billion to $4.9 billion implying conversion greater than 100%.
WHAT TO LOOK FOR
Full-year free cash flow, fiscal 2026
Free cash flow between $4.7 billion and $4.9 billion SourceWHERE TO FIND ITCompany-reported cash flow statement / full-year earnings release (Q4 2026 call)

KNOWABLE AFTER2027-02-15
fcf · made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Though oil price cost is dollar neutral, it impacts margin rate by 20 basis points which we will mitigate through higher volume and better productivity resulting in operating margin expansion in line with our prior expectations.
WHAT TO LOOK FOR
Full-year operating margin (operating income as % of net sales), fiscal year 2026
Operating margin expansion year-over-year in line with prior guidance of approximately 100 basis points (accept range 80-120 bps expansion) SourceWHERE TO FIND ITCompany income statement / full-year earnings release and 10-K (FY2026)

KNOWABLE AFTER2027-02-15
operating_margin · made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
This impact is expected to be fully covered by the price actions we implemented in Q2.
WHAT TO LOOK FOR
Gross margin rate impact from raw material (oil) inflation being offset by pricing actions, as reflected in operating margin expansion
Full-year operating margin expansion consistent with prior guidance despite $150-175 million oil inflation (i.e., margin expansion not reduced due to unmitigated input cost inflation) SourceWHERE TO FIND ITCompany income statement and management commentary on margin drivers (10-K / Q4 earnings call)

KNOWABLE AFTER2026-12-31
made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We now estimate oil inflation $150 million to $175 million up from $125 million previously.
WHAT TO LOOK FOR
Full-year raw material (oil-related) cost inflation impact, as disclosed by company
Reported oil inflation impact between $150 million and $175 million for fiscal year 2026 SourceWHERE TO FIND ITCompany earnings release / management commentary on Q4 2026 earnings call or 10-K

KNOWABLE AFTER2027-02-15
oil_wti · made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
EPS guidance is increasing from a range of $8.50 to $8.70 to $8.80 to $8.95, a growth of 9% to 11% year over year.
WHAT TO LOOK FOR
Full-year diluted adjusted EPS, fiscal year 2026
Adjusted EPS between $8.80 and $8.95 SourceWHERE TO FIND ITCompany full-year earnings release / 10-K (adjusted EPS reconciliation)

KNOWABLE AFTER2027-02-15
eps · made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are raising organic growth expectations from 3% to greater than 3.5% for the year.
WHAT TO LOOK FOR
Full-year organic sales growth, company total
Full-year organic sales growth > 3.5% SourceWHERE TO FIND ITCompany income statement / earnings release (organic growth reconciliation, FY2026 Q4 report)

KNOWABLE AFTER2027-01-31
revenue · made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
These efforts are translating into commercial results with 5 year new product sales reaching about $4 billion this year and new product vitality index climbing to the mid teens this year, and 20% next year.
WHAT TO LOOK FOR
5-year new product sales (annual dollar figure) and new product vitality index (%)
5-year new product sales approx $4 billion for fiscal 2026 (this year); new product vitality index in mid-teens (14-16%) for fiscal 2026 and approx 20% for fiscal 2027 SourceWHERE TO FIND ITCompany investor presentations / earnings call management commentary (10-K or investor day slides disclosing new product vitality index and 5-year new product sales)

KNOWABLE AFTER2027-12-31
made Jul 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect performance to continue accelerating as we leverage AI to move more quickly from idea generation to development and production.
WHAT TO LOOK FOR
New product vitality index (5-year new product sales as % of total sales)
New product vitality index >= 20% for fiscal year 2026 SourceWHERE TO FIND ITCompany-disclosed vitality index (earnings release / investor presentation)

KNOWABLE AFTER2027-01-31
made Jul 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
While reducing development cycle time by about 20%.
WHAT TO LOOK FOR
Product development cycle time (as reported/disclosed by 3M's R&D organization)
Reduction in development cycle time >= 20% versus baseline cited by management SourceWHERE TO FIND ITManagement commentary on earnings calls or investor presentations (3M R&D/innovation disclosures)

KNOWABLE AFTER2027-12-31
made Jul 21, 2026 · for by 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are increasing the pace of innovation and are on track to nearly triple the number of new products introduced this year versus 3 years ago, and launch more than 1 thousand products by 2027.
WHAT TO LOOK FOR
Cumulative number of new products launched by 3M since the baseline period, as disclosed by the company
Cumulative new product launches by 2027 > 1,000 SourceWHERE TO FIND ITCompany-disclosed innovation metrics (investor presentations, earnings calls, or annual report)

KNOWABLE AFTER2027-12-31
made Jul 21, 2026 · for by 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
and putting us on track to deliver more than 350 new products this year.
WHAT TO LOOK FOR
Total new product launches for fiscal year 2026, as reported by company
Full-year new product launches > 350 SourceWHERE TO FIND ITmanagement commentary on quarterly earnings calls / company disclosures (Q4 2026 or full-year 2026 results)

KNOWABLE AFTER2027-01-31
made Jul 21, 2026 · for FY2026
2026 Q2 (33)33 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
we expect organic growth in the second quarter to be higher than 3%, with all the 3 BGs accelerating. SIBG, which was at 3.2%, obviously going higher than that. TEBG, low single digit. And CBG flat to positive.
Test pending
revenue · made Apr 21, 2026 · due Jun 30, 2026
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Backlog conversion and continued order strength is expected to support growth momentum in both SIBG and TEBG in the second quarter.
Test pending
made Apr 21, 2026 · due Jun 30, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
So it's -- I think it's a great combination in a space that we like quite a bit... It is going to be accretive to our growth, margins, earnings over time.
WHAT TO LOOK FOR
Growth rate, gross/operating margin, and EPS contribution attributable to the Madison/SCBA joint venture, as disclosed by company
Company reports/confirms the JV is accretive to revenue growth, margins, and earnings (i.e., positive contribution vs. dilutive or neutral) within the stated timeframe SourceWHERE TO FIND ITCompany disclosures (10-K/10-Q segment discussion, earnings call commentary on SCBA/Madison JV performance)

KNOWABLE AFTER2028-04-21
made Apr 21, 2026 · due Apr 21, 2028
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Our 2026 financial outlook puts us on pace to exceed our medium-term financial commitments that we laid out during Investor Day around growth, margin and cash.
WHAT TO LOOK FOR
Full-year 2026 results vs. medium-term financial commitments (revenue growth, operating margin, and free cash flow / cash conversion) laid out at Investor Day
FY2026 reported revenue growth, operating margin, and cash conversion each exceed the low end of the medium-term targets given at Investor Day SourceWHERE TO FIND ITCompany quarterly/annual earnings releases and investor presentations referencing Investor Day medium-term targets (10-K, Q4 2026 earnings call)

KNOWABLE AFTER2027-02-15
made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
the strong backlog combined with continued strength in orders in the first 3 weeks of April gives us confidence that all 3 business groups will accelerate growth in the second quarter and through the balance of the year.
WHAT TO LOOK FOR
Organic sales growth rate by business group, Q2 vs Q1 (sequential acceleration), and for full-year vs Q1 pace
Each of the 3 business groups reports higher organic sales growth in Q2 2026 than in Q1 2026 SourceWHERE TO FIND ITCompany quarterly earnings release/10-Q segment disclosures and earnings call commentary

KNOWABLE AFTER2026-07-31
revenue · made Apr 21, 2026 · for Q2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
As we lap tariff pressure in the second half, the continued momentum on productivity and volume acceleration gives us confidence in our expectation of approximately 100 basis points margin expansion for business groups this year.
WHAT TO LOOK FOR
Full-year business group segment margin expansion (year-over-year change in operating margin for the business groups)
Business groups segment margin expansion between 85 and 115 basis points for fiscal year 2026 SourceWHERE TO FIND ITCompany full-year earnings release / 10-K segment reporting (business group margins)

KNOWABLE AFTER2027-02-15
operating_margin · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
that consistency and momentum gives us confidence that we can meet or exceed the medium-term goals we outlined at our Investor Day last year, even in an uncertain macro environment.
WHAT TO LOOK FOR
Company performance versus medium-term financial goals outlined at Investor Day (e.g., organic revenue growth, margin, EPS targets as defined at that event)
Reported medium-term metrics meet or exceed the specific targets communicated at the Investor Day SourceWHERE TO FIND ITCompany Investor Day materials (for original targets) and subsequent quarterly/annual earnings reports and management commentary through the medium-term horizon

KNOWABLE AFTER2027-12-31
made Apr 21, 2026 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
This will put us ahead of our Investor Day target to launch 1,000 new products through 2027.
WHAT TO LOOK FOR
Cumulative number of new products launched from the start of the count period through end of 2027
Cumulative new product launches > 1,000 by end of 2027 (ahead of the original Investor Day pace, i.e., trending to exceed 1,000 before year-end 2027) SourceWHERE TO FIND ITCompany management commentary / Investor Day updates and quarterly earnings calls disclosing new product launch counts

KNOWABLE AFTER2027-12-31
made Apr 21, 2026 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Looking forward, we remain confident in achieving our full year 2026 guidance despite the volatile environment.
WHAT TO LOOK FOR
Full-year fiscal 2026 non-GAAP EPS and organic revenue growth versus company's issued FY2026 guidance range
Reported full-year 2026 non-GAAP EPS and organic revenue growth fall within (or above) the guidance range issued by the company SourceWHERE TO FIND ITCompany press release / 10-K / Q4 2026 earnings call guidance reconciliation

KNOWABLE AFTER2027-02-15
revenue · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
we said this year that we will grow about $330 million, $300 million above macro. And as we get into the second half of the year, from the exit rates, you are right, we will be north of 3.5%
WHAT TO LOOK FOR
3M organic revenue growth rate, second half of fiscal 2026 (Q3+Q4)
Second-half organic growth > 3.5% SourceWHERE TO FIND ITCompany quarterly income statement / earnings release (organic growth reconciliation, Q3 and Q4 2026 reports)

KNOWABLE AFTER2027-01-31
revenue · made Apr 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capacityCONVICTIONStated expectation · “we expect”, “should”, “we see”
we will double capacity towards the back end of the year.
WHAT TO LOOK FOR
Production capacity for the relevant product/line referenced, as disclosed by management
Reported capacity >= 2x the level cited at time of the claim (baseline capacity), achieved by back half of 2026 SourceWHERE TO FIND ITManagement commentary on Q3/Q4 2026 earnings calls or investor presentations

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
It won't be a meaningful driver of the overall 3M growth in the year.
WHAT TO LOOK FOR
Segment revenue growth contribution to overall 3M organic growth for the year, versus segment's share as a meaningful driver
Segment growth is positive (>0%) but contributes less than proportionally to total 3M organic growth (i.e., segment growth rate below overall company organic growth rate) SourceWHERE TO FIND ITCompany-disclosed segment revenue results (10-K / Q4 earnings release and call)

KNOWABLE AFTER2027-02-15
made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
For the year, we expect to see some growth. It will be positive.
WHAT TO LOOK FOR
Full-year organic growth for the consumer/discretionary segment referenced (year-over-year)
Full-year growth rate > 0% SourceWHERE TO FIND ITCompany segment reporting (10-K / Q4 earnings call commentary)

KNOWABLE AFTER2027-01-31
made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we look at the balance of the year, we see electronics start to get modestly positive.
WHAT TO LOOK FOR
Electronics segment (TEBG electronics-related) organic sales growth rate, as reported quarterly
Full-year or second-half electronics organic growth rate > 0% SourceWHERE TO FIND ITCompany quarterly earnings release / segment commentary (10-Q/10-K and earnings call slides)

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
What we've seen so far and expect is about $125 million of cost increase there, which are offsetting into pricing. As I mentioned earlier on that we expect about a 50 basis point uplift on price coming from that oil-based exposure.
WHAT TO LOOK FOR
Oil-based raw material cost increase (polychem exposure) and corresponding price uplift
Disclosed/implied cost increase approximately $125 million AND price uplift approximately 50 basis points (within +/- 20% of stated figures) SourceWHERE TO FIND ITManagement commentary on subsequent earnings calls / 10-K raw material cost commentary

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
any pre-buy that's happened will wash out in Q2, but we do see acceleration in the back half on the back of really core operating fundamentals around NPI and commercial excellence.
WHAT TO LOOK FOR
Organic revenue growth rate, second half of fiscal year (Q3+Q4) compared to first half growth rate
H2 organic revenue growth rate higher than H1 organic revenue growth rate SourceWHERE TO FIND ITQuarterly earnings releases and management commentary on Q2, Q3, Q4 earnings calls

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Yes, we see Q2 being better than Q1. And we see the second half being better than the first half, is the way we're currently looking at it, Jeff.
WHAT TO LOOK FOR
Organic revenue growth rate by quarter/half (Q1 vs Q2, H1 vs H2)
Q2 organic growth rate > Q1 organic growth rate, AND H2 organic growth rate > H1 organic growth rate SourceWHERE TO FIND ITCompany quarterly earnings releases and 10-Q/10-K organic growth disclosures

KNOWABLE AFTER2027-01-31
revenue · made Apr 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
On EPS, given the contingencies for the second half, we expect the first-half EPS to be higher than the second half.
WHAT TO LOOK FOR
Diluted (or adjusted) EPS for first half of fiscal year 2026 vs second half of fiscal year 2026
First-half 2026 EPS > second-half 2026 EPS SourceWHERE TO FIND ITQuarterly income statements / earnings releases for Q1-Q4 2026 (10-Q and 10-K filings)

KNOWABLE AFTER2027-02-15
eps · made Apr 21, 2026 · for H1 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We anticipate consumer to improve as point of sale is on an upward trend, resulting in normalized inventory levels.
WHAT TO LOOK FOR
Consumer segment point-of-sale trend and channel inventory levels, as described in management commentary
Management reports point-of-sale trend continuing upward and channel/distributor inventory levels described as normalized (not elevated) by year-end SourceWHERE TO FIND ITCompany earnings call management commentary and investor presentations (Q2-Q4 2026 calls)

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Regarding cadence, we expect sales growth to accelerate in Q2 and the back half of the year.
WHAT TO LOOK FOR
Consolidated net sales growth rate (YoY %), quarterly
Q2 2026 YoY sales growth rate higher than Q1 2026 YoY sales growth rate, with Q3 and Q4 2026 growth rates also higher than Q1 SourceWHERE TO FIND ITCompany quarterly income statement / earnings release (10-Q, 10-K)

KNOWABLE AFTER2027-01-31
revenue · made Apr 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are facing higher input costs due to the recent increase in oil price, but have implemented targeted price increases to mitigate the impact at the current levels.
WHAT TO LOOK FOR
Company-wide gross margin (or segment margin expansion) for fiscal year 2026, as reported
Full-year gross margin expansion consistent with maintained EPS guidance despite oil-related input cost increases (i.e., EPS guidance range for FY2026 is met or exceeded) SourceWHERE TO FIND IT10-K / Q4 2026 earnings release and management commentary on full-year results

KNOWABLE AFTER2027-01-31
oil_wti · made Apr 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
free cash flow conversion of greater than 100%.
WHAT TO LOOK FOR
Free cash flow conversion (free cash flow as a percentage of net income), fiscal year
Free cash flow conversion > 100% SourceWHERE TO FIND ITCompany-reported free cash flow and net income in fiscal year 10-K / Q4 earnings release

KNOWABLE AFTER2027-02-15
fcf · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
earnings per share ranging from $8.50 to $8.70
WHAT TO LOOK FOR
Full-year diluted earnings per share (adjusted, as guided)
Full-year EPS between $8.50 and $8.70 SourceWHERE TO FIND ITCompany income statement / earnings release and investor guidance reconciliation (Q4/full-year earnings report)

KNOWABLE AFTER2027-01-31
eps · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Organic sales growth of approximately 3%, earnings per share ranging from $8.50 to $8.70 and free cash flow conversion of greater than 100%.
WHAT TO LOOK FOR
Full-year organic sales growth, full-year diluted EPS, and full-year free cash flow conversion (FCF/net income)
Organic sales growth between 2.5% and 3.5% AND full-year EPS between $8.50 and $8.70 AND free cash flow conversion > 100% SourceWHERE TO FIND ITCompany full-year earnings release and 10-K (income statement, cash flow statement, and management guidance reconciliation)

KNOWABLE AFTER2027-02-15
revenue · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
we believe our free cash flow will be more than $4.5 billion for the year and greater than 100% conversion.
WHAT TO LOOK FOR
Full-year free cash flow and free cash flow conversion (FCF / net income)
Free cash flow > $4.5 billion AND conversion > 100% SourceWHERE TO FIND ITCompany cash flow statement / full-year earnings release (Q4/FY 2026 call)

KNOWABLE AFTER2027-01-31
fcf · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
On nonoperational, we expect positive trends driven by a $2 billion share repurchase in the first quarter and lower net interest expense.
WHAT TO LOOK FOR
Net interest expense (nonoperational item) year-over-year change, fiscal year
Full-year net interest expense lower than prior year's reported figure SourceWHERE TO FIND ITCompany income statement / earnings release (10-K or Q4 call)

KNOWABLE AFTER2027-02-15
eps · made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capacityCONVICTIONStated expectation · “we expect”, “should”, “we see”
we're investing to more than double our capacity to support growing AI demand.
WHAT TO LOOK FOR
Manufacturing capacity for EBO/data center optical connector products (e.g., production capacity metric as disclosed by management)
Company-disclosed capacity for this product line >= 2x the capacity level at time of statement (2026-04-21) SourceWHERE TO FIND ITManagement commentary on quarterly earnings calls or investor presentations discussing data center/EBO capacity

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
It positions us to maintain above-market growth, enhance margins and drive strong free cash flow generation.
WHAT TO LOOK FOR
Combined fire and safety business (Scott Safety + Madison Fire & Rescue) revenue growth rate versus relevant end-market/industry growth rate, plus segment margin trend
Fire and safety business organic revenue growth exceeds cited end-market growth rate, with segment operating margin flat or higher year-over-year SourceWHERE TO FIND ITCompany segment disclosures and management commentary (10-K/10-Q and quarterly earnings calls)

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Electronics orders were up double digits due to significant activity in semis and data centers, which will convert to revenue in Q2 and the second half.
WHAT TO LOOK FOR
Electronics segment revenue growth, year-over-year, Q2 and second-half fiscal periods
Electronics segment revenue growth accelerates to positive/higher growth in Q2 and H2 versus the flat Q1 year-over-year growth reported SourceWHERE TO FIND ITCompany segment revenue disclosure (10-Q / quarterly earnings call commentary on Electronics vertical)

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · for H2 FY26
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capexCONVICTIONStated expectation · “we expect”, “should”, “we see”
we're investing more than $250 million over the next 3 years in standard, easy-to-replicate automation across our plants and distribution centers.
WHAT TO LOOK FOR
Cumulative capital investment in automation across plants and distribution centers over the 3-year period
Cumulative disclosed automation investment >= $250 million SourceWHERE TO FIND ITManagement commentary / investor disclosures on capex allocation (earnings calls, investor presentations)

KNOWABLE AFTER2029-04-21
capex · made Apr 21, 2026 · for FY2028
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
we're on pace to launch 350 in 2026.
WHAT TO LOOK FOR
Total new product launches, full year 2026
New products launched in 2026 >= 350 SourceWHERE TO FIND ITmanagement commentary on quarterly earnings calls / company disclosures (e.g., Q4 2026 or FY2026 call)

KNOWABLE AFTER2027-01-31
made Apr 21, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
But we saw encouraging order trends that support our outlook for acceleration in the balance of the year.
WHAT TO LOOK FOR
Organic revenue growth rate, quarterly, for remaining quarters of fiscal 2026
Organic growth in Q2, Q3, or Q4 2026 exceeds Q1 2026's 1.2% rate SourceWHERE TO FIND ITQuarterly earnings release / income statement (organic growth disclosure)

KNOWABLE AFTER2026-12-31
revenue · made Apr 21, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.demandCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
Again, I think CE, or consumer electronics, may soften a little bit. But we are seeing better trajectory and growth in the data center and the semiconductor business.
WHAT TO LOOK FOR
Electronics segment (TEBG) organic growth trajectory, specifically relative performance of consumer electronics vs. data center/semiconductor sub-businesses
Company commentary or disclosed segment data shows data center/semiconductor growth outpacing consumer electronics, with consumer electronics growth flat-to-declining, over the remaining quarters of fiscal 2026 SourceWHERE TO FIND ITQuarterly earnings call management commentary and segment disclosures (10-Q/10-K) for Transportation and Electronics segment

KNOWABLE AFTER2026-12-31
made Apr 21, 2026 · due Dec 31, 2026
2026 Q1 (32)32 open
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
I feel good that we will outgrow the macro next year. at this year at '26 as a result of some of the initiatives we have in place on NPI and commercial excellence.
WHAT TO LOOK FOR
Company organic revenue growth rate versus broader macro/market growth rate for fiscal 2026
Company FY2026 organic revenue growth > relevant market/GDP-proxy growth rate cited by management SourceWHERE TO FIND ITCompany quarterly earnings releases and FY2026 10-K, management commentary on macro comparison

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
So we do see a higher in '26 than '25 in terms of market outgrowth, and it is exactly from the progress made on innovation and five-year new product sales coming up.
WHAT TO LOOK FOR
3M organic sales growth (%) minus estimated end-market/industrial macro growth (%), i.e. market outgrowth, fiscal year 2026
2026 market outgrowth (organic growth minus macro) greater than the 2025 reported market outgrowth figure, and in dollar terms above $300 million versus macro SourceWHERE TO FIND ITCompany-disclosed organic growth and market outgrowth commentary (10-K / quarterly earnings calls, FY2026)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
we are pretty confident that those are going to start to move the needle for the company, which is why we feel good about the outgrowing the macro here in '26.
WHAT TO LOOK FOR
Company organic revenue growth versus estimated end-market/macro growth rate, fiscal year 2026
FY2026 organic revenue growth exceeds management's stated macro growth estimate (~1.5%-1.7%) SourceWHERE TO FIND ITCompany quarterly/annual earnings releases and management commentary on macro vs. company growth (10-K/10-Q and earnings calls)

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
So you know, our outperformance, you know, this year versus the macro is more like $300 million or more.
WHAT TO LOOK FOR
Company's revenue outperformance versus estimated macro/IPI growth, fiscal year 2026 (self-reported by management, calculated as actual revenue growth minus macro growth rate applied to base)
Outperformance versus macro >= $300 million as stated/calculated by management SourceWHERE TO FIND ITManagement commentary on FY2026 earnings calls (Q4 2026 / full-year results call) or investor presentations discussing organic growth versus macro/IPI benchmark

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
with a little bit of consumer recovery, you will see that coming through in a CBG business this year.
WHAT TO LOOK FOR
CBG (Consumer Business Group) segment organic sales growth and/or margin performance, fiscal year 2026
CBG organic sales growth > 0% and/or full-year segment margin higher than fiscal 2025 reported figure SourceWHERE TO FIND ITCompany segment reporting (10-K / quarterly earnings releases, CBG segment disclosures)

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
I would expect margin growth as we get into 2026 as well as a really level out the business.
WHAT TO LOOK FOR
CBG segment operating margin (gross margin or operating margin, as reported), full year 2026 vs full year 2025
Full-year 2026 CBG margin higher than full-year 2025 CBG margin (basis-point improvement year-over-year) SourceWHERE TO FIND ITCompany segment reporting (10-K / quarterly earnings releases and call commentary on CBG margin)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
I just come back to with the execution of the team in commercial excellence and NPI, I think they are doing a very good job. I expect it will outperform that industrial macro as we get into '26.
WHAT TO LOOK FOR
Company's industrial segment organic growth rate versus industrial macro/end-market growth rate, fiscal 2026
Company industrial segment organic growth > industrial macro growth rate for FY2026 SourceWHERE TO FIND ITCompany quarterly earnings releases and management commentary (10-K/10-Q segment results and call transcripts) through FY2026

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
I expect the same thing here in '26.
WHAT TO LOOK FOR
Company's China segment revenue growth rate relative to overall China industrial production (IPI) market growth rate, fiscal year 2026
Company's China growth rate exceeds the low-to-mid-single-digit market/IPI growth rate cited for the period SourceWHERE TO FIND ITManagement commentary on earnings calls (regional performance commentary) and 10-K geographic segment disclosures

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.macro economyCONVICTIONStated expectation · “we expect”, “should”, “we see”
we see that market to be more low to mid-single digits this year. Still growing, maybe not as robustly as we saw last year, but still low to mid-single digits.
WHAT TO LOOK FOR
Company revenue growth rate (year-over-year) in China region for fiscal 2026
Low to mid-single digit percentage growth, i.e., between 1% and 6% SourceWHERE TO FIND ITCompany-disclosed regional revenue commentary (10-K geographic segment disclosure / earnings call commentary)

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Last year, we did $185 million. We are going to do an incremental $225 million this year. The stranded cost goes up from $100 million last year to $150 million this year.
WHAT TO LOOK FOR
Stranded costs, fiscal year 2026 (as disclosed by management, dollar amount)
Full-year 2026 stranded costs reported at approximately $150 million (within $135-165 million range) SourceWHERE TO FIND ITManagement commentary on earnings calls / investor presentations (FY2026 results, Q4 2026 call)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So overall, we are going to see about a 125 to $150 million increase between volume and productivity in '26.
WHAT TO LOOK FOR
Combined increase in operating income from volume and productivity, fiscal year 2026 vs 2025
Increase between $125 million and $150 million (volume ~$250M + productivity ~$600M vs 2025's $750M combined) SourceWHERE TO FIND ITCompany management commentary / segment operating income disclosures (10-K or Q4 2026 earnings call)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
With 3% growth, the $200 million of volume will now become closer to $250 million, and productivity actually goes up from $550 million to about $600 million.
WHAT TO LOOK FOR
Fiscal year 2026 operating income increase attributable to volume and productivity (company-disclosed components, in $ millions)
Volume contribution approximately $250 million AND productivity contribution approximately $600 million (combined increase in the $850-$925 million range, i.e., $125-150 million higher than 2025's $750 million) SourceWHERE TO FIND ITManagement commentary / investor presentation on FY2026 results (Q4 2026 earnings call or 10-K)

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Just firstly, you look at both volume and productivity in 2026, it is going to be higher than what it was in 2025.
WHAT TO LOOK FOR
Combined operating income contribution from volume and productivity, fiscal year (as broken out in management commentary)
2026 combined volume + productivity operating income increase > $750 million (FY2025 level) SourceWHERE TO FIND ITCompany earnings call / investor presentation disclosing volume and productivity operating income bridge

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
largely, I think, you are heading in the right direction. I think you know, SABG is performing really well. We would expect to continue that trend here in 2026.
WHAT TO LOOK FOR
SABG (Safety and Industrial business group, or successor segment name) organic sales growth, fiscal year 2026
FY2026 SABG organic sales growth > 0%, consistent with continuation of the reported growth trend SourceWHERE TO FIND ITCompany segment reporting (10-K / quarterly earnings releases and call commentary)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
No. We are not seeing it being more margin dilutive.
WHAT TO LOOK FOR
Segment (electronics) operating margin trend as expansion into mainstream/cost-designed products continues
Segment operating margin does not decline year-over-year (i.e., no margin degradation attributable to mainstream product mix) SourceWHERE TO FIND ITCompany segment reporting (10-K/10-Q segment margin disclosures, quarterly earnings calls)

KNOWABLE AFTER2026-12-31
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
even though IPI is coming down, you know, our commercial initiatives, our NPI initiatives, it is going to allow us to get to outperform that macro, and we expect that to accelerate in '26 from what we have experienced in '25.
WHAT TO LOOK FOR
Company organic sales growth rate relative to overall electronics end-market growth rate (outperformance gap)
FY2026 organic growth outperformance versus market/IPI benchmark is greater than FY2025 outperformance (i.e., the growth gap widens year over year) SourceWHERE TO FIND ITmanagement commentary and organic sales growth disclosures in quarterly earnings calls/10-K (FY2026 results and full-year 2026 call)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
we can continue to see good pricing movement here going into 2026.
WHAT TO LOOK FOR
Company-reported price contribution to sales growth (as disclosed in earnings/segment commentary)
Reported price/pricing contribution is positive (> 0%) in FY2026 quarters SourceWHERE TO FIND ITCompany earnings releases and management commentary on quarterly calls (FY2026)

KNOWABLE AFTER2026-12-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Regarding cadence, we expect the rate of sales growth to increase through the year, with margin and EPS equal between the two halves.
WHAT TO LOOK FOR
Quarterly sales growth rate (year-on-year) progression through fiscal 2026, and operating margin and EPS split between H1 and H2
Q4 2026 YoY sales growth rate > Q1 2026 YoY sales growth rate, AND H1 vs H2 2026 operating margin within 0.3 percentage points of each other, AND H1 vs H2 2026 adjusted EPS within 5% of each other SourceWHERE TO FIND ITQuarterly income statement and segment sales data (10-Q/10-K filings and quarterly earnings releases)

KNOWABLE AFTER2027-01-31
revenue · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
Adjusted free cash flow conversion is expected to be greater than 100%, driven by strong operating income growth and a focus on working capital management.
WHAT TO LOOK FOR
Adjusted free cash flow conversion (adjusted free cash flow / adjusted net income, as reported by company)
Adjusted free cash flow conversion > 100% for fiscal year 2026 SourceWHERE TO FIND ITCompany earnings release / 10-K adjusted free cash flow reconciliation (FY2026 Q4 report)

KNOWABLE AFTER2027-02-15
fcf · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Overall, we expect total company income to grow by $400 million at the midpoint of our 70 to 80 basis points margin expansion guide.
WHAT TO LOOK FOR
Total company operating income growth (fiscal year 2026 vs fiscal year 2025) and operating margin expansion in basis points
Operating income growth approximately $400 million and operating margin expansion between 70 and 80 basis points SourceWHERE TO FIND ITCompany income statement and segment/margin disclosures (10-K / Q4 2026 earnings release and call)

KNOWABLE AFTER2027-02-15
operating_income · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Corporate and other income will be lower by $50 to $75 million, or 20 to 30 basis points, largely from the wind-down of transition services agreements related to Solventum.
WHAT TO LOOK FOR
Year-over-year change in Corporate and Other income (segment reconciliation), fiscal year 2026
Corporate and Other income declines by $50 million to $75 million versus fiscal 2025 (allow $40-$85 million range for approximate match) SourceWHERE TO FIND ITCompany 10-K / Q4 2026 earnings release segment reporting (Corporate and Other reconciliation)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
This will be partially offset by headwinds from PFAS, stranded costs, and tariff impacts, as well as an increase in growth and productivity investments to $225 million.
WHAT TO LOOK FOR
Growth and productivity investments, full fiscal year 2026
Full-year 2026 growth and productivity investment approximately $225 million (within 10% of target) SourceWHERE TO FIND ITCompany earnings release / 10-K management commentary on investment spend (FY2026 results)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
The business groups combined will expand margins over $450 million or 100 basis points, including $875 million from volume growth and net productivity across supply chain and G&A.
WHAT TO LOOK FOR
Combined business-group segment operating margin expansion (year-over-year change in margin percentage/basis points) for fiscal year 2026
Combined business-group operating margin increases by approximately 100 basis points (or approximately $450 million) year-over-year, i.e. >= 90 basis points SourceWHERE TO FIND ITCompany segment reporting / earnings release and 10-K for fiscal year 2026

KNOWABLE AFTER2027-02-15
operating_margin · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
SIBG and TEBG grew 2.7% combined in 2025, and we expect this growth rate will accelerate in 2026, supported by ongoing commercial excellence initiatives, strong service levels, and continued new product introductions.
WHAT TO LOOK FOR
Combined organic sales growth rate of SIBG (Safety and Industrial Business Group) and TEBG (Transportation and Electronics Business Group) segments, full year 2026
Combined SIBG + TEBG growth rate > 2.7% SourceWHERE TO FIND ITCompany segment reporting (10-K / Q4 2026 earnings release and call)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect organic sales growth to be approximately 3%, earnings per share ranging from $8.5 to $8.7, and free cash flow conversion of greater than 100%.
WHAT TO LOOK FOR
Full-year organic sales growth, GAAP-to-adjusted diluted EPS, and free cash flow conversion (FCF/net income), fiscal year 2026
Organic sales growth approximately 3% (2.5%-3.5%); EPS between $8.50 and $8.70; free cash flow conversion greater than 100% SourceWHERE TO FIND ITCompany FY2026 earnings release and 10-K (income statement, cash flow statement, and non-GAAP reconciliation)

KNOWABLE AFTER2027-01-31
revenue · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
adjusted operating margin expansion of 70 to 80 basis points
WHAT TO LOOK FOR
Adjusted operating margin expansion, full fiscal year 2026 vs. full fiscal year 2025
Adjusted operating margin increase of 70 to 80 basis points versus FY2025 adjusted operating margin SourceWHERE TO FIND ITCompany financial results / full-year earnings release (10-K or Q4 2026 earnings call, adjusted operating margin reconciliation)

KNOWABLE AFTER2027-02-15
operating_margin · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
This year, we expect organic sales growth of approximately 3%, adjusted operating margin expansion of 70 to 80 basis points, and earnings per share of $8.5 to $8.7, and free cash flow conversion greater than 100%.
WHAT TO LOOK FOR
Full-year 2026 organic sales growth %, adjusted operating margin expansion (bps year-over-year), diluted adjusted EPS, and free cash flow conversion %
Organic sales growth ~3% (2.5%-3.5%); adjusted operating margin expansion 70-80 bps; adjusted EPS between $8.50 and $8.70; free cash flow conversion > 100% SourceWHERE TO FIND ITCompany FY2026 earnings release and 10-K (income statement, segment/margin disclosures, and free cash flow reconciliation)

KNOWABLE AFTER2027-02-15
revenue · made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
with a target of 5.4% cost of quality in 2026 and less than 4% over time.
WHAT TO LOOK FOR
Cost of poor quality as a percentage of cost of goods sold, full fiscal year 2026
Cost of quality <= 5.4% for fiscal year 2026 SourceWHERE TO FIND ITCompany management commentary / investor presentations on quality metrics (earnings call or shareholder letter)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect this growth to continue with 350 launches in 2026.
WHAT TO LOOK FOR
Number of new product launches in fiscal year 2026
New product launches >= 350 SourceWHERE TO FIND ITCompany-disclosed product launch count (earnings call or annual report, FY2026)

KNOWABLE AFTER2027-01-31
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
if that plays out exactly as we expect and evolve the trade flows I mentioned, you know, it could be a $30 million, $40 million impact this year.
WHAT TO LOOK FOR
Tariff-related cost impact from US-Europe trade flows, as disclosed by management for fiscal year 2026
Disclosed or implied impact between $30 million and $40 million for the year SourceWHERE TO FIND ITManagement commentary on quarterly earnings calls (Q1-Q4 2026) or 10-K/10-Q disclosures on tariff impact

KNOWABLE AFTER2026-12-31
made Jan 20, 2026 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
It is probably going to be in line with that. I cannot really tell you if it is going to be up or down. I mean, it depends on what happens in the overall docket, but I would expect it to be, you know, pretty similar to that.
WHAT TO LOOK FOR
Litigation-related costs/adjustment (as disclosed in company adjusted earnings reconciliation), fiscal year 2026
Full-year 2026 litigation cost adjustment between $450 million and $550 million (approximately in line with the ~$500 million 2025 figure) SourceWHERE TO FIND ITCompany financial disclosures / adjusted earnings reconciliation (10-K or quarterly earnings release)

KNOWABLE AFTER2027-02-15
made Jan 20, 2026 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.macro economyCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
We are planning for the macro to be similar to 2025, but it is still early to put too much weight on market forecasts.
WHAT TO LOOK FOR
Full-year 2026 organic sales growth (as reported by the company)
Organic sales growth approximately 3% (2.5%-3.5% range) SourceWHERE TO FIND ITCompany earnings release / 10-K (FY2026 results, reported Q4 2026 or early 2027)

KNOWABLE AFTER2027-02-15
gdp_growth · made Jan 20, 2026 · due Dec 31, 2026
2025 Q4 (26)26 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
we are raising our earnings per share guidance for the year from a range of $7.75 to $8 to a range of $7.95 to $8.05 representing an approximately $0.12 increase at the midpoint or 10% growth for the year.
Test pending
eps · made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Our strong performance through the first 3 quarters of the year enables us to increase our earnings per share guidance to $7.95 to $8.05
Test pending
eps · made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Commercial vehicles is down. It was down -- I think it's going to be just north of 20% here in the back half of the year.
Test pending
made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
At the midpoint of the guidance, we would be 100 basis points of margin expansion. Now if we continue to perform the way we have in terms of either higher volume like in the third quarter or more on the margin side, we could be at the higher end of the guidance range, which would imply a margin expansion of 150 basis points in the fourth quarter for us.
Test pending
operating_margin · made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
So I think it's quite typical. If you look year-over-year, which is the more appropriate comparison, we do believe that we will grow above macro again in the fourth quarter.
Test pending
revenue · made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
This is something that we're going to continue to work on. We don't size it today. We'll give updates to investors over time. It will not be a big bang. We'll shape more next quarter. This quarter of $14 million next quarter. It will be in that same range, about $15 million.
Test pending
made Oct 21, 2025 · due Jan 31, 2026
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We continue to expect free cash flow conversion of greater than 100% with absolute free cash flow dollars being higher reflecting the increase in earnings.
Test pending
fcf · made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
on the back of this performance, we are updating our margin expansion expectations to 180 to 200 basis points for the year.
Test pending
operating_margin · made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
As such, we do not expect this divestiture to be dilutive to earnings.
Test pending
eps · made Oct 21, 2025 · due Jan 31, 2026
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
sales from products launched in the last 5 years up 30% in Q3 and 16% year-to-date, tracking to be up high teens for the full year.
Test pending
made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
we now expect to launch over 250 new products this year, exceeding our goal of 215 and pacing ahead of our Investor Day target of 1,000 new products through 2027.
Test pending
made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
we now expect full year organic sales growth to be greater than 2% with adjusted free cash flow conversion remaining above 100%.
Test pending
revenue · made Oct 21, 2025 · due Dec 31, 2025
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
And next year, we see a line of sight because of commercial excellence, NPI to get there.
WHAT TO LOOK FOR
Cumulative incremental revenue/growth contribution from Investor Day initiatives, next fiscal year (2026)
Reported cumulative contribution for 2026 >= $300 million (i.e., cumulative total >= $400 million including the $100 million from this year) SourceWHERE TO FIND ITCompany-disclosed Investor Day progress update (quarterly earnings calls / investor presentations in 2026)

KNOWABLE AFTER2026-12-31
made Oct 21, 2025 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
So where we sit today, we actually feel very good about the 25% target that we set out for '27.
WHAT TO LOOK FOR
Company operating margin (or the specific margin metric referenced in the 25% target), full fiscal year
Fiscal 2027 margin >= 25.0% SourceWHERE TO FIND ITCompany financial statements / investor day or earnings materials disclosing full-year margin (10-K, Q4 2027 earnings release)

KNOWABLE AFTER2028-02-15
operating_margin · made Oct 21, 2025 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
this is all about how do you grow and accelerate our margin expansion journey beyond 25% by '27, that's not where we're going to stop.
WHAT TO LOOK FOR
Company-wide operating margin (as reported, full fiscal year)
Full-year operating margin for FY2027 > 25% SourceWHERE TO FIND ITCompany income statement / annual report (10-K) and management commentary on FY2027 results

KNOWABLE AFTER2028-02-15
operating_margin · made Oct 21, 2025 · due Dec 31, 2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
While the macroeconomic outlook is uncertain, we will outperform by scaling commercial excellence across all business units and leveraging new product launches.
WHAT TO LOOK FOR
Full-year organic revenue growth rate relative to end-market/macro growth (as characterized by management)
2026 organic revenue growth reported as above macro/market growth (directional; company frames outperformance qualitatively on earnings call) SourceWHERE TO FIND ITCompany FY2026 earnings release and Q4 2026 earnings call management commentary

KNOWABLE AFTER2027-01-31
revenue · made Oct 21, 2025 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
we have a long runway for improvement toward our target of achieving less than 4% cost of quality as a percentage of cost of goods sold.
WHAT TO LOOK FOR
Cost of quality (cost of poor quality) as a percentage of cost of goods sold, quarterly
Cost of quality as % of COGS < 4.0% SourceWHERE TO FIND ITCompany quarterly earnings call / investor presentation disclosure of cost of quality metric

KNOWABLE AFTER2026-10-21
made Oct 21, 2025 · due Oct 21, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
On the supply chain side, we said that we'll do $1 billion of productivity over the next 3 years. We did good this year, but we're also finding more opportunities... So you're going to see a little bit more on the productivity side next year.
WHAT TO LOOK FOR
Cumulative supply chain productivity savings disclosed toward the $1 billion, 3-year target, and/or explicit commentary on next year's productivity savings versus this year's
Company-reported or management-disclosed productivity savings for fiscal 2026 exceed fiscal 2025's productivity savings amount SourceWHERE TO FIND ITCompany management commentary / investor presentations on productivity savings (earnings calls, 10-K or investor day slides)

KNOWABLE AFTER2027-01-31
made Oct 21, 2025 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So I think overall, you will see next year again to be a strong operating performance here.
WHAT TO LOOK FOR
Cumulative productivity/margin savings versus Investor Day 3-year target, next fiscal year (FY2026) contribution
FY2026 incremental savings >= $300 million (in line with cumulative target of $400 million by end of FY2026) SourceWHERE TO FIND ITCompany Investor Day target refresh / management commentary on quarterly earnings calls (FY2026)

KNOWABLE AFTER2027-01-31
operating_margin · made Oct 21, 2025 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
as we get into '26, Amit, I think what we are going to see is continued outperformance versus the macro.
WHAT TO LOOK FOR
Company organic/net sales growth rate relative to broader macro/end-market growth (as characterized by management in commentary), fiscal year 2026
Company-reported 2026 organic sales growth rate exceeds management's cited macro/market growth rate (qualitative outperformance confirmed in commentary or via reported growth differential > 0 percentage points) SourceWHERE TO FIND ITCompany quarterly earnings releases and earnings call commentary (FY2026 quarters), 10-K/10-Q

KNOWABLE AFTER2027-02-15
revenue · made Oct 21, 2025 · due Dec 31, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
This will grow over time. And again, it's -- we're not going to be at 50-50 Class 3 versus Class 4s and Class 5s, but you'll see more 4s and 5s come in into the pipeline into next year and into 2027.
WHAT TO LOOK FOR
Mix of new product launches by class, Class 4/Class 5 share of total launches (as reported/discussed by management)
Class 4/Class 5 launch share increases from the current ~20% baseline by 2027 SourceWHERE TO FIND ITmanagement commentary on earnings calls (product launch mix disclosures) through 2027

KNOWABLE AFTER2027-12-31
made Oct 21, 2025 · for FY2027
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
Finally, we continue to expect to deliver cash flow conversion that exceeds 100%.
WHAT TO LOOK FOR
Free cash flow conversion (free cash flow as a percentage of net income), full fiscal year
Cash flow conversion > 100% SourceWHERE TO FIND ITCompany financial statements / earnings release (FY2025 and FY2026 full-year results)

KNOWABLE AFTER2026-02-15
fcf · made Oct 21, 2025 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
For EPS, we expect operational performance to be the primary driver of earnings growth similar to this year.
WHAT TO LOOK FOR
Operating earnings growth contribution vs. non-operational (interest, FX, tax, buybacks) contribution to EPS growth, fiscal year 2026
Operational performance (revenue growth, margin expansion) accounts for the majority (>50%) of year-over-year adjusted EPS growth in FY2026 SourceWHERE TO FIND ITCompany management commentary / EPS bridge disclosed in 10-K or Q4 2026 earnings call materials

KNOWABLE AFTER2027-01-31
eps · made Oct 21, 2025 · for FY2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Alongside growth, we will improve productivity in our supply chain and G&A to more than offset investments, stranded costs and anticipated tariff impacts, resulting in margin expansion in 2026.
WHAT TO LOOK FOR
Full-year operating margin (or adjusted operating margin), fiscal year 2026
FY2026 operating margin higher than FY2025 reported operating margin SourceWHERE TO FIND ITCompany income statement / earnings release segment and margin disclosures (10-K and Q4 2026 earnings call)

KNOWABLE AFTER2027-02-15
operating_margin · made Oct 21, 2025 · for FY2026
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
We think it might soften a little bit in Q4. I don't know what's actually going to happen because the team is pushing pretty hard.
Test pending
made Oct 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
Q3 was up high single digits, around 8%. So it's -- it was better than we had expected. We had expected a softening in the back half. And in fact, it accelerated a little bit in Q3, now it might weaken a little bit in Q4 but still be up.
Test pending
made Oct 21, 2025 · due Dec 31, 2025
2025 Q3 (29)29 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
it helps us with maintaining reasonable fit GILTI rates, which is important to us, helps us maintain our effective tax rate in the 20% range, which is what we had anticipated and hoped for.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
we know that's going to drive growth in the back half.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
we know A&D is going to be picking up for us in the back half.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
If volume comes up, I think the operating leverage should be north of 35% in the second half or in time to come.
Test pending
operating_margin · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
On the operating leverage piece, we should see that flow through. Okay. Today, our operating leverage is about -- I mean, incremental is about 35%. That will probably be the same, if not go higher.
Test pending
operating_margin · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we go through the course of the year, in our current margin guide of 150 to 200 basis points. You should see all 3 business groups doing well. SIBG and CPG will definitely do better. TEBG a little bit lighter because of the stranded cost that you pointed out, but the productivity is flowing through well there.
Test pending
operating_margin · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect to be in the high 80s now by the end of the year. The team tells me they want to exit the year at 90%.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do expect us to be flattish in the back half from being down in the front half, even though the builds are still weak in the back half.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
again, it will slow down, but still be up for the year.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do expect it will slow down in the back half. That's embedded in our numbers.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
So it's -- we're offsetting $0.20 of gross tariff with both cost and sourcing changes, which is about half of the offset and the other half is coming through price.
Test pending
eps · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
we're starting to see benefits of lower churn in the back half.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
So we see electronics, it's still up in the back half. It's just not as strong in the front half.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.macro economyCONVICTIONStated expectation · “we expect”, “should”, “we see”
On ForEx, our headwind on the EPS for the year is about $0.05.
Test pending
eps · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
if you take a step back and you look at it year-over-year, you're still seeing the second half margins go up by 110 basis points at the midpoint of our guidance.
Test pending
operating_margin · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
In terms of EPS, Q3 is historically higher than Q4, and -- that's what is is because seasonally, our revenue is higher in Q3 than in Q4 and also on the margin side, it's higher. The ratio has been, if you look at the second half, 52% of the EPS of the second half is in Q3, about 48% is in Q4. So we kind of expect the same trend this year as well.
Test pending
eps · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
In the first half, we grew 1.5%. So that would imply a 2.5% growth in the back half. And we're expecting probably Q3 and Q4 to grow at similar levels around there.
Test pending
revenue · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
we do see the back half on safety accelerating there as well because of both a couple of wins that we've had, but some new product introductions.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Electrical markets remain very robust for us. Again, we expect that to be high single digits going into the back half.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
For the year, we're expecting about the same and again, we're getting about 2% gross productivity, 2% net productivity on top of inflation.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
I think the -- we should be expecting both improvements in growth from new product innovation as well as improving margin as you're bringing a product to market.
Test pending
gross_margin · made Jul 18, 2025 · due Jun 30, 2026
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
this includes an approximately $0.50 to $0.55 benefit from volume growth and continued productivity net of stranded cost and growth investments, which is partially offset by $0.30 to $0.35 of tariff impact and higher interest expense.
Test pending
eps · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Regarding the second half, we expect year-on-year earnings growth of $0.18 at the midpoint.
Test pending
eps · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
we now expect an operational benefit of $0.95 to $1.20, partially offset by $0.50 of tariff, FX and non-op headwinds for a total EPS growth of 6% to 10%.
Test pending
eps · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
On the back of a strong first half performance, we now expect margin expansion of 150 to 200 basis points and are increasing both the lower and higher end of our EPS range
Test pending
operating_margin · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are updating our organic revenue growth guidance to approximately 2% and expect all 3 business groups to grow low single digits for the year with a similar profile to the first half.
Test pending
revenue · made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
In the first half of the year, we returned $3 billion to shareholders via dividends and share repurchases, and we'll continue to be opportunistic on buybacks in the second half of the year while preserving balance sheet flexibility.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
tracking well to be up more than 15% for the year.
Test pending
made Jul 18, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capexCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
To the extent that things look a little bit better in the back half into '26, then we'll let it a little bit more out.
Test pending
made Jul 18, 2025 · due Jun 30, 2026
2025 Q2 (17)17 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we go through the year, we do expect all three business groups margins to expand.
Test pending
operating_margin · made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do expect all three business groups to expand their margins for 2025.
Test pending
operating_margin · made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
But the reality is we see that to be a kind of modest growth flattish to modest growth for us for this year.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect our auto OE business to be down mid-single digits both in the quarter and for the year.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
It's probably trending more towards the higher end.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
But you know, the team has been very smart and surgical about how we do this. So so we outside of the macro erosion, you know, we're not expecting much much demand deterioration from a volume perspective. Because of the way we're being smart about pricing.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
So sequentially, also, we should see about $0.10 to $0.15 benefit on the EPS.
Test pending
eps · made Apr 22, 2025 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Now sequentially, you're correct. It's seasonally, you know, revenue should be up about $300 million should come with good flow through.
Test pending
revenue · made Apr 22, 2025 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
For the second quarter, we may see a couple of pennies here and there, small impact, but that's within the guidance range of $7.60 to $7.90.
Test pending
eps · made Apr 22, 2025 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Julian, again, listen, as we said, the tariffs started in February with non-USMCA aluminum steel but the ones with the biggest impact started in April, particularly with between US and China. And as I mentioned, we typically carry about 90 days of inventory. So we will see this impact in more mainly in the second half of the year.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
So overall, if you put all of that together for the first half, our EPS will grow about $0.22 to $0.27.
Test pending
eps · made Apr 22, 2025 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
On cash, we continue to expect approximately 100% adjusted free cash flow conversion
Test pending
fcf · made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect the operational cadence of sales and EPS to be split equally between the first and second half in line with historical performance.
Test pending
eps · made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect this $0.07 of timing items to be earnings neutral for the first half of the year.
Test pending
eps · made Apr 22, 2025 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Tariffs are going to be a headwind this year, but we thought it would be prudent to hold the impact outside of our full-year guidance while I digest the new policies and fully develop and qualify mitigation plans.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
Safety and industrial was up 2 points to about 82%. It's on a steep climb to achieve 90% by year-end.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
We're on track to launch 215 new products this year and 1,000 over the next three years.
Test pending
made Apr 22, 2025 · due Dec 31, 2025
2025 Q1 (13)13 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
No, it will be a net positive in this year. Yes.
Test pending
made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
So we feel very positive about that. So we see that getting a little bit better here in '25.
Test pending
made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We should end '25 at over $6 billion in cash.
Test pending
made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As you move into '25, you should see margin expansion again in TEBG.
Test pending
operating_margin · made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
But whatever we've seen in terms of launches, is built into the two to three guidance we see next year.
Test pending
revenue · made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
This will result in Q1 earnings being similar to that of last year and we expect sequential improvement into Q2 as we lap the Solventum spin items with earnings being approximately equal between the two halves.
Test pending
eps · made Jan 21, 2025 · due Jun 30, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Within the first half, we expect Q1 sales growth to be similar to Q4 and earnings will reflect the annual equity grants, which last year were deferred to Q2.
Test pending
revenue · made Jan 21, 2025 · due Mar 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we think about the cadence through the year, we expect sales and EPS to be split equally between the first and second half, in line with historical trends.
Test pending
revenue · made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capexCONVICTIONStated expectation · “we expect”, “should”, “we see”
Adjusted CapEx of approximately $1 billion will be in line with depreciation and amortization.
Test pending
capex · made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
This is just the start as our goal is to get to 75 days, freeing up cash for our capital deployment priorities
Test pending
made Jan 21, 2025 · due Jan 21, 2026
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our goal remains to deliver 2% net productivity through sourcing efficiency, quality improvement, lean manufacturing and asset utilization
Test pending
made Jan 21, 2025 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONStated expectation · “we expect”, “should”, “we see”
In 2025, we expect to see a double-digit increase in the number of launches on top of the higher performance in '24
Test pending
made Jan 21, 2025 · due Dec 31, 2025
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
These efforts are starting to take hold and will support further gross margin expansion toward our goal of high 40s.
WHAT TO LOOK FOR
Consolidated gross margin (%)
Gross margin trending upward toward high-40s% (47-49%) SourceWHERE TO FIND ITQuarterly income statement / earnings release

KNOWABLE AFTER2025-12-31
gross_margin · made Jan 21, 2025 · due -
2024 Q4 (14)14 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
It gives us confidence to expand operating margins next year while driving top line growth, and we will give more specific details this year.
Test pending
operating_margin · made Oct 22, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Look, we don’t see on the horizon going out through next year big liability payments that aren’t already on our balance sheet.
Test pending
made Oct 22, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
No, Brett, it should be declined substantially going into next year. I mean we will lap the year, so there will be a little bit of drag on effect for things that happen in the course of ‘24. But we shouldn’t see significant headwind from portfolio or geographic prioritization going into next year.
Test pending
made Oct 22, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.laborCONVICTIONStated expectation · “we expect”, “should”, “we see”
So, the negative is essentially inflation that we will see over there, which is a wage inflation moving forward.
Test pending
made Oct 22, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
And as I step back and you put all that stuff together and turn the corner into ‘25, we should see better growth. That would be my expectation.
Test pending
revenue · made Oct 22, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As I laid out sort of the math there and earlier in this conversation, $13 billion worth of cost of goods, if we do 2% net productivity, it’s more or less $260 million. If we did it every year, it’s sort of a point a year of gross margin.
Test pending
gross_margin · made Oct 22, 2024 · due Oct 22, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
We intend to ramp up our recovery efforts in the coming days and weeks. And we do expect our insurers to honor their policy obligations to us in full.
Test pending
made Oct 22, 2024 · due Jan 22, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are looking to drive 2% net productivity, so 2% net of inflation across all those elements, including in supply chain.
Test pending
made Oct 22, 2024 · due Oct 22, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Transportation and Electronics, up low single-digits and consumer down low single-digits.
Test pending
made Oct 22, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect our full year adjusted organic growth to be approximately 1%, with business group estimates unchanged, with safety and industrial flat to up low single-digits.
Test pending
revenue · made Oct 22, 2024 · due Dec 31, 2024
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
But I do see that that’s a big focus of ours. We have got to be really pushing that hard to drive gross margin improvement over time.
WHAT TO LOOK FOR
Company-wide gross margin (gross profit as % of net sales), annual
Full-year gross margin higher than prior fiscal year's reported gross margin SourceWHERE TO FIND ITAnnual income statement (10-K) or Q4/full-year earnings release

KNOWABLE AFTER2026-10-22
gross_margin · made Oct 22, 2024 · due Oct 22, 2026
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
And we do expect in years to come the cap – as earnings grow, we make progress in working capital, especially in the area of inventory, this will increase our cash flow and keep the conversion higher than 100%.
WHAT TO LOOK FOR
Free cash flow conversion (free cash flow divided by net income), annual
Cash flow conversion > 100% for fiscal year 2025 and/or fiscal year 2026 SourceWHERE TO FIND ITCompany annual report / 10-K and earnings call cash flow disclosures

KNOWABLE AFTER2026-10-22
fcf · made Oct 22, 2024 · for FY2029
OPENVERDICTDeadline not reached yet; the claim is still on the clock.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
This is a football metaphor. It’s a couple of yards and a pile of dust in lots of ways to get ground game going on operations excellence. It’s a multi-quarter, multi-year journey. So the way I look at this, I think we’re still, Jeff, in the early innings of becoming operationally excellent. And I think the bulk of the opportunities are ahead of us, which is why I think as I look out the next 1, 2, 3 years, we should continue to see margin growth coming out of a lot of what’s happening across our factory network.
WHAT TO LOOK FOR
Gross margin and/or operating margin, annual, as reported
Gross margin (or operating margin) higher than prior fiscal year for fiscal years 2025, 2026, and 2027 SourceWHERE TO FIND ITCompany income statement (10-K / annual earnings release)

KNOWABLE AFTER2027-10-22
operating_margin · made Oct 22, 2024 · for FY2025-27
OPENVERDICTDeadline not reached yet; the claim is still on the clock.growthCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
That will start to bear fruit into next year, maybe the end of next year and into ‘26.
WHAT TO LOOK FOR
Company revenue growth rate relative to end market growth rate (organic sales growth vs. market GDP/end-market growth proxy)
Company organic sales growth rate exceeds cited end-market growth rate (~2.5-2.7% GDP proxy) by end of 2026 SourceWHERE TO FIND ITmanagement commentary and reported organic revenue growth in quarterly earnings releases/10-K

KNOWABLE AFTER2026-12-31
made Oct 22, 2024 · for FY2026
2024 Q3 (27)27 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Please note that in the month of July we will make total combined payments of $3.7 billion related to the Public Water Supplies and Combat Arms settlements.
Test pending
made Jul 26, 2024 · due Jul 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Based on what we know right now, the team feels the guide that we have given you, which is for the company as a whole, is fair.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
This year in our sort of 1% center point of our 0 to 2 guidance, we have positive price within that.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
And then tax rate for the third quarter will be in the range of 20% to 21%.
Test pending
made Jul 26, 2024 · due Sep 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
And then you will see -- we talked about $0.11 EPS impact for the second half on Combat Arms and PWS.
Test pending
eps · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Restructuring costs based on what the team sees right now is flat Q2 to Q3.
Test pending
made Jul 26, 2024 · due Sep 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We will see lower fees as Solventum begins to exit. And that's an impact of approximately $0.09 from a headwind on an EPS perspective, which is overall still in the range 2Q was heavier than 3Q and 4Q.
Test pending
eps · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
You will get a tailwind from the timing of stock comp, which we announced in 2Q, approximately 100 of it that comes back as a tailwind in Q3.
Test pending
eps · made Jul 26, 2024 · due Sep 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
If you now go to just the guidance between 2Q, 3Q or 3Q, 4Q, 3Q revenue trends will be very similar to what we saw in 2Q.
Test pending
revenue · made Jul 26, 2024 · due Sep 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So the tax rate will be around 19% in the second half versus 20% in the first half.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We spent $165 million in the first half on restructuring, and at the midpoint that would be another $110 million in the second half.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our interest costs, interest expense is going to go up. Our interest income will come down in the back half of the year.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do see some headwinds in our factories. We built inventory through the second quarter that caused some positive absorption. We'll see inventory coming down in the back half of the year. That's going to cause some negative absorption or some headwinds there
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We'll see some tailwinds from the benefit of lower restructuring cost, which is now 60/40 first half, second half.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do expect revenue to be very similar in the second half to the first half, and that does reflect historical trends.
Test pending
revenue · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capexCONVICTIONStated expectation · “we expect”, “should”, “we see”
We do expect that we have some capacity in the back half to incrementally invest in the business.
Test pending
capex · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
You're right. We've been through and are actually getting through a very substantial restructuring program, about 75% complete. It will drag into 2025.
Test pending
made Jul 26, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
We've done a very good job at the covering inflation and we'll see some incrementally positive pricing this year.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
And finally consumer is down nearly 3% organically through the first half of the year versus a full year expectation of down low single digits.
Test pending
revenue · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
On an adjusted basis, transportation and electronics is up nearly 5% organically in the first half versus a full year expectation of up low single digits.
Test pending
revenue · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Full year adjusted organic growth remains unchanged at flat to up 2% with expectations for second half organic growth in line with first half performance at the midpoint.
Test pending
revenue · made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We remain in discussion with multiple carriers and anticipate additional future recoveries.
Test pending
made Jul 26, 2024 · due Jan 26, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Year-to-date Other had an operating loss of $28 million which is in line with our full year expectation of flat to a loss of $25 million.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
This is in line with our full year anticipated sales range of $225 million to $275 million with a forecasted adjusted operating loss in the range of $125 million to $175 million.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Taking into account our first half of the year performance, we now expect our full year non-operating expense to be in the range of $50 million to $75 million versus a prior range of $75 million to $100 million.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
For the full year we continue to expect pretax restructuring charges in the range of $250 million to $300 million.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.productCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
This year we'll do probably less than 150.
Test pending
made Jul 26, 2024 · due Dec 31, 2024
2024 Q2 (26)26 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
No, Deane, we're committed to that exit. We're on track, and we're committed to follow through.
Test pending
made Apr 30, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We are on track to meet our commitment by the end of 2025 and are working closely with each of our customers to complete an orderly transition.
Test pending
made Apr 30, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
So there's a little bit of drag next year, but I -- it's not big. I would just say the first half of this year will be slightly heavier than the second.
Test pending
made Apr 30, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
And then on semiconductor, our view is we saw the first quarter slow, and we believe that this will pick up in the second half, Andy.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Q2, as I mentioned, will continue to benefit from the interest income that we receive from the -- dividend that we receive from Solventum of $7.7 billion. And so therefore, the $75 million to the $100 million guide for the year will mostly be weighted to the second half of the year.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Similarly, you mentioned it too and I said that in my prepared remarks, we will incur stock-based compensation headwind around $120 million to $150 million.
Test pending
made Apr 30, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Restructuring charges are between $250 million to $300 million for the year. 70% is weighted to the first half.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So on revenue, the first half, second half is 49-51. And then the margin split first half, second half is 47-53.
Test pending
operating_margin · made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect to seek Board approval to declare the second quarter dividend in May with payments anticipated in June.
Test pending
made Apr 30, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
As a result, we anticipate a dividend of approximately 40% of adjusted free cash flow.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
These actions are estimated to create a year-on-year organic growth headwind for the Consumer business of approximately 2 percentage points.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
And in Consumer, we estimate organic sales to be down low single digits, which includes our ongoing product portfolio initiatives.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We estimate organic sales growth in Safety and Industrial to be flat to up low single digits.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As disclosed in our Form 10-K, stock-based compensation grants were delayed to Q2. As a result, we expect to incur $125 million to $150 million in expense in Q2.
Test pending
made Apr 30, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we have previously discussed, we estimate annualized dis-synergies of approximately $150 million to $175 million.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect full year Corporate and Unallocated net operating loss in the range of $125 million to $175 million.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
Finally, Corporate and Unallocated includes full year 2024 sales in the range of $225 million to $275 million for commercial agreements with Solventum beginning in April.
Test pending
revenue · made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
This range includes first quarter net operating loss of approximately $65 million on a continuing operations basis. Beginning in April, transition service agreements costs plus a markup will be reimbursed to 3M, and therefore, we will generate modest income in the remaining 3 quarters of the year.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
And our 2024 adjusted tax rate is expected to be in the range of 19% to 20% with the first half of the year coming in at the high end of the range.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect adjusted operating income and earnings per share to show relative strength in the second half of the year.
Test pending
operating_margin · made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
We also anticipate an approximately 75 basis point benefit to sales from the commercial agreement with Solventum.
Test pending
revenue · made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.macro economyCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our expectations also include a 1% foreign currency headwind to sales given the strength of the U.S. dollar at current spot rates or a negative $0.20 to earnings per share.
Test pending
revenue · made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
We anticipate full year adjusted organic growth of flat to up 2% or up 1% to 3% excluding the impact from geographic prioritization and product portfolio initiatives we are taking.
Test pending
revenue · made Apr 30, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We anticipate making total payments with a pretax present value of up to $10.3 billion over the next 13 years. The first payment is expected in the third quarter of 2024.
Test pending
made Apr 30, 2024 · due Sep 30, 2024
OPENVERDICTDeadline not reached yet; the claim is still on the clock.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We anticipate making total payments up to a pretax present value of $5.3 billion through 2029.
WHAT TO LOOK FOR
Cumulative pretax present value of payments made under the Combat Arms multi-district litigation settlement
Cumulative disclosed settlement payments (pretax present value basis) <= $5.3 billion through 2029, with progress tracking toward that cap over the period SourceWHERE TO FIND ITCompany 10-K/10-Q disclosures and management commentary on litigation settlement liabilities and payments

KNOWABLE AFTER2029-12-31
made Apr 30, 2024 · for FY2029
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
What I would tell you is second half is so important for the consumer electronics business, and we are watching that trend. If there is a big pickup in consumer electronics, we will definitely grow with it because we are now specced in to many more devices than before.
Test pending
made Apr 30, 2024 · due Dec 31, 2024
2024 Q1 (17)17 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We are going to exit and complete by the end of 2025. That's everybody's focused on that goal.
Test pending
made Jan 23, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We're committed to that what we announced to exit PFAS manufacturing by the end of 2025.
Test pending
made Jan 23, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
In total, I still feel good that the range of $700 million to $900 million is good for the overall program.
Test pending
made Jan 23, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
We also remain on schedule to exit all PFAS manufacturing by the end of 2025, with production volumes down 20%.
Test pending
made Jan 23, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
2024 outlook assumes we will have selling prices year-on-year. It's helping us offset some of the moderate inflation we are seeing in certain raw materials, and then the labor market continues to remain strong.
Test pending
made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Q1 looks to us a lot like Q4.
Test pending
made Jan 23, 2024 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
In the first quarter, non-op pension will be a $0.04 per share headwind to adjusted earnings.
Test pending
eps · made Jan 23, 2024 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
Overall, our restructuring program remains on-track to deliver pretax savings in the range of $700 million to $900 million with a similar level of charges upon completion.
Test pending
made Jan 23, 2024 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We anticipate pre-tax restructuring charges in the range of $250 million to $350 million and incremental savings in the range of $150 million to $250 million.
Test pending
made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
As Mike mentioned, these actions are estimated to create a year-on-year organic growth headwind of approximately $100 million or 2 percentage points.
Test pending
revenue · made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Health Care's organic sales growth is anticipated to be flat to up low-single-digits year-on-year.
Test pending
made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect continued strong margin expansion, along with another year of strong cash flow with an adjusted conversion rate of 95% to 105%.
Test pending
fcf · made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Excluding the impact from geographic prioritization and portfolio actions, we expect organic growth of 1% to 3%.
Test pending
revenue · made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capexCONVICTIONStated expectation · “we expect”, “should”, “we see”
In 2024, for example, we expect to complete the investments in state-of-the-art water filtration technology across our chemical manufacturing sites.
Test pending
capex · made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
In addition, the upcoming spin-off our Health Care business will further strengthen our balance sheet.
Test pending
made Jan 23, 2024 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
We are planning on holding an investor meeting later this year, following the spin of Health Care where we will provide an update to our full year 2024 guidance along with our medium-term financial framework.
Test pending
made Jan 23, 2024 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We continue to expect the business to be spun-off with an estimated net leverage of 3x to 3.5x EBITDA, and with the proceeds to be distributed to 3M prior to the completion of the spin.
Test pending
made Jan 23, 2024 · due Jun 30, 2024
2023 Q4 (11)11 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
this program will take approximately two years to complete out, you can see the overall, long-term benefits from the margin rate that you're going to get from better operating performance as well as better restructuring benefits.
Test pending
operating_margin · made Oct 24, 2023 · due Jan 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Auto electrification is on track to be a $600 million business this year and has delivered organic growth of 30% year to date.
Test pending
made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
it's somewhere in that 20.5% to 21% for the fourth quarter.
Test pending
operating_margin · made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
based on where we are with the midpoint of our guide, our margin rate will be approximately 20%.
Test pending
operating_margin · made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONStated expectation · “we expect”, “should”, “we see”
We came into the quarter -- into the year, we said low single digits price increase. That's what we are -- as of right now, we are on track with pretty much the same range.
Test pending
made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect Q4 to look a lot like Q3 in our end markets, and I would say electronics included.
Test pending
made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capexCONVICTIONStated expectation · “we expect”, “should”, “we see”
our capital allocation, first priority is going to be investing in organic growth in R&D and CapEx.
Test pending
capex · made Oct 24, 2023 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Looking ahead to the implied fourth quarter, we expect end market trends to be consistent with Q3.
Test pending
made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We now estimate a full year sales decline for disposable respirators of approximately $600 million versus $550 million previously.
Test pending
made Oct 24, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
the anticipated one-time dividend from the spin of health care at leverage of three to three and a half times EBITDA and 19.9% retained stake will provide additional financial flexibility.
Test pending
made Oct 24, 2023 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We continue to expect full year pre-tax restructuring benefits of $400 million to $450 million with offsetting charges.
Test pending
made Oct 24, 2023 · due Dec 31, 2023
2023 Q3 (18)18 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
Nicole, I'll add one more is we are very confident and bullish about this business. In fact, we have added capacity to continue to have more production output out there as the demand comes back.
Test pending
made Jul 25, 2023 · due Jul 25, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.regulationCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
And we have announced that 3M will exit all PFAS manufacturing by the end of 2025.
Test pending
made Jul 25, 2023 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.supply chainCONVICTIONStated expectation · “we expect”, “should”, “we see”
I would say in the long term, you should see trends continue to improve from an inventory turns perspective. Because as supply chains heal, as we get better on demand planning, that's why you're going to see it. So you will see it get better in the long run.
Test pending
made Jul 25, 2023 · due Jan 25, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
So as I've mentioned, there is slight improvement that you're going to see in -- overall in Health Care.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
As Monish outlined, we're going to see more to the high end of our range of what we expected for disposable respirator declines in the year which means in third quarter, we'll see an impact from that as well.
Test pending
made Jul 25, 2023 · due Sep 30, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.otherCONVICTIONStated expectation · “we expect”, “should”, “we see”
And then, on -- I would just say on another housekeeping item is other financial, when we came into the year, we had said it would be minus 10% to flat on a year-over-year basis. We are updating that to minus 5% to flat -- minus 5% to plus 5% which on the midpoint is 0.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
What we are watching also is, to answer some other of your points, raw material and energy cost inflation coming into the year was $150 million to $250 million. We have now changed that to $150 million to $200 million.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We've given you 2023, we expect 2024 charges by the end of 2024 to have pretty much taken most of the restructuring charges. The benefits, of course, show up in '25 and beyond.
Test pending
made Jul 25, 2023 · due Dec 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
The total program, as a reminder, is between $700 million to $900 million of charge and $700 million to $9 million -- $900 million of benefits.
Test pending
made Jul 25, 2023 · due Dec 31, 2025
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
We have attached an appendix that shows you by quarter where we expect to be for 2023 which is charges in the range of $400 million to $450 million and benefits in the range of $400 million to $450 million, so self-funding.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
And so we expect some destocking to continue in the electronics channel.
Test pending
made Jul 25, 2023 · due Sep 30, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Health care elective procedures, we believe, will continue to go up on a sequential basis.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
And finally, our full year adjusted free cash flow conversion expectation remains unchanged in a forecasted range of 90% to 100%.
Test pending
fcf · made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect this trend to continue into the second half of the year.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect our year-on-year organic growth rates in electronics to remain negative in the second half, however, improve versus down nearly 30% in the first half as we start to lap easier comps.
Test pending
made Jul 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
In addition, our proven access to capital markets, along with the anticipated onetime dividend from the spin of Health Care at 3 to 3.5x EBITDA and 19.9% retained stake, will provide additional financial flexibility.
Test pending
made Jul 25, 2023 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
We continue to work towards closing the transaction by year-end 2023 or early 2024, subject to the required conditions and additional factors we have disclosed in our SEC filings.
Test pending
made Jul 25, 2023 · due Mar 31, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
I would say the conversation is something that we anticipate as we see disinflation and eventually, we see deflation, then we would expect it to ramp up.
Test pending
made Jul 25, 2023 · due Jan 25, 2024
2023 Q2 (15)15 open
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONHigh conviction · “confident”, “clear line of sight”, absolute language
The actions we announced today will enable us to exit 2023 stronger than we started and provide for significant margin and cash flow improvement into the future.
Test pending
operating_margin · made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
So, currently, our view on stranded costs ultimately depends on the revenue of ParentCo too is between 50 basis points to 75 basis points, so much lower than benchmark.
Test pending
made Apr 25, 2023 · due Jun 30, 2024
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
As we think about the second half, that’s where supply chains, our belief is supply chain start healing, which means we should be able to see better cost – product cost from our factories as well as the cost from sourcing.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our view is that as China stabilizes as we start seeing our comps ease compared to last year, fourth quarter should be on a much more normal run rate, which means on a year-over-year basis, it will show positive growth.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
And as supply chains continue to heal, we should start also seeing the productivity or cost reductions in our cost of goods to start showing up in the second half.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.macro economyCONVICTIONStated expectation · “we expect”, “should”, “we see”
Our full year guidance, as I have talked about, assumes overall recovery in all economies in the second half, including China.
Test pending
gdp_growth · made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.marginsCONVICTIONStated expectation · “we expect”, “should”, “we see”
And the benefits from that program are also $700 million to $900 million. And we expect the benefits – half of those benefits also to show up in 2023.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
But with that said, just for the year, again, we are maintaining guidance, which includes the restructuring charge of $700 million to $900 million for the program. We expect half of that will be incurred in 2023.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect organic sales volumes will improve as consumer retail and consumer electronics markets stabilize, China work through its COVID-related challenges as our year-on-year comps ease.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.costsCONVICTIONStated expectation · “we expect”, “should”, “we see”
This range also incorporates the continued softness in organic sales and expected increase in investments, higher non-op interest costs and an adjusted tax rate of 18.5% to 19.5%.
Test pending
made Apr 25, 2023 · due Jun 30, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.growthCONVICTIONStated expectation · “we expect”, “should”, “we see”
Organic sales is expected to be down low to mid-single digits, which includes the forecasted year-on-year headwind of approximately 1.5% from disposable respirators.
Test pending
revenue · made Apr 25, 2023 · due Jun 30, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.capital allocationCONVICTIONStated expectation · “we expect”, “should”, “we see”
While we will remain disciplined, we expect to increase investments as we progress through the year to support end-market demand improvement in the second half and into the future.
Test pending
made Apr 25, 2023 · due Dec 31, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
We expect both sequential and year-on-year increase in auto bills, while healthcare procedure volumes are anticipated to be similar to Q1 levels and industrial end markets are expected to remain mixed.
Test pending
made Apr 25, 2023 · due Jun 30, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.demandCONVICTIONStated expectation · “we expect”, “should”, “we see”
The softness we experienced in Q1 in consumer electronics and consumer retail is expected to continue into Q2.
Test pending
made Apr 25, 2023 · due Jun 30, 2023
OVERDUEVERDICTPast its deadline, awaiting the next reporting evidence.pricingCONVICTIONHedged language · “we hope”, “could”, “if conditions allow”
And at the same time, as we have said before, if we continue to see inflation, we will readjust as needed.
Test pending
made Apr 25, 2023 · due Dec 31, 2023